Skip navigation

Chemical Xanthines

1–50 of 1,133 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. 1,3-dipropyl-8-cyclopentylxanthine vasodilation Glyburide 1,3-dipropyl-8-cyclopentylxanthine promotes the reaction [Glyburide results in decreased vasodilation] 1: Rattus norvegicus Ileum | Blood Vessels 1 gene: ADORA2A 1
2. 1,3-dipropyl-8-cyclopentylxanthine vasodilation Glucose 1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [Glucose results in increased vasodilation] 1: Rattus norvegicus Jejunum | Blood Vessels 1 gene: ADORA2A 1
3. 1,3-dipropyl-8-cyclopentylxanthine cell growth APP | cordycepin 1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [cordycepin inhibits the reaction [APP protein modified form results in decreased cell growth]] Hippocampus | Neurons | Cells, Cultured   1
4. 1,3-dipropyl-8-cyclopentylxanthine calcium ion import across plasma membrane APP | cordycepin 1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [cordycepin inhibits the reaction [APP protein modified form results in increased calcium ion import across plasma membrane]] Hippocampus | Neurons | Cells, Cultured   1
5. 1,7-dimethyluric acid exogenous drug catabolic process Caffeine | Quercetin [[Quercetin affects exogenous drug catabolic process] which affects the metabolism of Caffeine] which results in increased abundance of 1,7-dimethyluric acid 1: Homo sapiens Urine 1 gene: CYP2A6 1
6. 1,7-dimethylxanthine regulation of blood pressure 1,7-dimethylxanthine affects regulation of blood pressure 1: Homo sapiens Cardiovascular System   1
7. 1,7-dimethylxanthine exogenous drug catabolic process Caffeine | Quercetin [[Quercetin affects exogenous drug catabolic process] which affects the metabolism of Caffeine] which results in decreased abundance of 1,7-dimethylxanthine 1: Homo sapiens Plasma
2 genes: CYP1A2 | CYP2A6
1
8. 1,7-dimethylxanthine exogenous drug catabolic process Caffeine | Quercetin [[Quercetin affects exogenous drug catabolic process] which affects the metabolism of Caffeine] which results in decreased abundance of 1,7-dimethylxanthine 1: Homo sapiens Urine
2 genes: CYP1A2 | CYP2A6
1
9. 1,7-dimethylxanthine drug catabolic process Rifampin [Rifampin results in increased drug catabolic process] which results in increased chemical synthesis of 1,7-dimethylxanthine 1: Homo sapiens Hepatocytes | Cell Line, Tumor 1 gene: CYP1A2 1
10. 1,7-dimethylxanthine drug catabolic process Rifampin [Rifampin results in increased drug catabolic process] which results in increased chemical synthesis of 1,7-dimethylxanthine 1: Homo sapiens Hepatocytes | Cells, Cultured 1 gene: CYP1A2 1
11. 1,7-dimethylxanthine drug catabolic process Methylcholanthrene [Methylcholanthrene results in increased drug catabolic process] which results in increased chemical synthesis of 1,7-dimethylxanthine 1: Homo sapiens Hepatocytes | Spheroids, Cellular 1 gene: CYP1A2 1
12. 1-Methyl-3-isobutylxanthine histamine secretion mediated by immunoglobulin Mitoxantrone 1-Methyl-3-isobutylxanthine inhibits the reaction [Mitoxantrone results in increased histamine secretion mediated by immunoglobulin] 1: Rattus norvegicus Peritoneal Cavity | Mast Cells   1
13. 1-Methyl-3-isobutylxanthine histamine secretion mediated by immunoglobulin Mitoxantrone 1-Methyl-3-isobutylxanthine inhibits the reaction [Mitoxantrone results in increased histamine secretion mediated by immunoglobulin] 1: Rattus norvegicus Pleural Cavity | Mast Cells   1
14. 1-Methyl-3-isobutylxanthine lipid catabolic process 1-Methyl-3-isobutylxanthine results in increased lipid catabolic process 2: Cavia | Oryctolagus cuniculus Adipocytes
29 genes: ABHD2 | CES1D | CLIC3 | DAGLB | ENPP2 | FH | IRS1 | LIPA | LIPC | LIPE | LPL | MGLL | MITF | NCEH1 | NEU1 | PCK1 | PLA2G16 | PLA2G2A | PLA2G4C | PLBD2 | PLCB1 | PLCD3 | PLCH2 | PLD3 | PLIN1 | PNPLA2 | PNPLA3 | PNPLA6 | RARRES3
1
15. 1-Methyl-3-isobutylxanthine lipid catabolic process Brimonidine Tartrate Brimonidine Tartrate inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased lipid catabolic process] 2: Cavia | Oryctolagus cuniculus Adipocytes
29 genes: ABHD2 | CES1D | CLIC3 | DAGLB | ENPP2 | FH | IRS1 | LIPA | LIPC | LIPE | LPL | MGLL | MITF | NCEH1 | NEU1 | PCK1 | PLA2G16 | PLA2G2A | PLA2G4C | PLBD2 | PLCB1 | PLCD3 | PLCH2 | PLD3 | PLIN1 | PNPLA2 | PNPLA3 | PNPLA6 | RARRES3
1
16. 1-Methyl-3-isobutylxanthine lipid catabolic process Clonidine Clonidine inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased lipid catabolic process] 3: Canis lupus familiaris | Cavia | Oryctolagus cuniculus Adipocytes
29 genes: ABHD2 | CES1D | CLIC3 | DAGLB | ENPP2 | FH | IRS1 | LIPA | LIPC | LIPE | LPL | MGLL | MITF | NCEH1 | NEU1 | PCK1 | PLA2G16 | PLA2G2A | PLA2G4C | PLBD2 | PLCB1 | PLCD3 | PLCH2 | PLD3 | PLIN1 | PNPLA2 | PNPLA3 | PNPLA6 | RARRES3
1
17. 1-Methyl-3-isobutylxanthine lipid catabolic process Phenylisopropyladenosine Phenylisopropyladenosine inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased lipid catabolic process] 2: Cavia | Oryctolagus cuniculus Adipocytes
29 genes: ABHD2 | CES1D | CLIC3 | DAGLB | ENPP2 | FH | IRS1 | LIPA | LIPC | LIPE | LPL | MGLL | MITF | NCEH1 | NEU1 | PCK1 | PLA2G16 | PLA2G2A | PLA2G4C | PLBD2 | PLCB1 | PLCD3 | PLCH2 | PLD3 | PLIN1 | PNPLA2 | PNPLA3 | PNPLA6 | RARRES3
1
18. 1-Methyl-3-isobutylxanthine lipid catabolic process Alprostadil Alprostadil inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased lipid catabolic process] 2: Cavia | Oryctolagus cuniculus Adipocytes
29 genes: ABHD2 | CES1D | CLIC3 | DAGLB | ENPP2 | FH | IRS1 | LIPA | LIPC | LIPE | LPL | MGLL | MITF | NCEH1 | NEU1 | PCK1 | PLA2G16 | PLA2G2A | PLA2G4C | PLBD2 | PLCB1 | PLCD3 | PLCH2 | PLD3 | PLIN1 | PNPLA2 | PNPLA3 | PNPLA6 | RARRES3
1
19. 1-Methyl-3-isobutylxanthine cell differentiation Dexamethasone | INS | PD 068235 PD 068235 inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased cell differentiation] 1: Mus musculus 3T3-L1 Cells
171 genes: AAMP | ABHD5 | ACVR1C | ADIRF | AGO2 | AGRN | AKT1 | ANGPT1 | ANGPTL4 | ANKRD49 | ARHGAP22 | ARHGEF2 | ARHGEF28 | BCL7B | BEX1 | BMP4 | BMP6 | BMP7 | BMPR1A | BNC1 | C9ORF24 | CAPRIN2 | CCDC136 | CDC42 | CDK6 | CEBPA | CEBPB | CENPF | CEP131 | CHRDL1 | CLIC4 | COL15A1 | CREB1 | CSF1 | CSRP2 | CTBP2 | CTNNB1 | DLK1 | DMKN | DOCK7 | DUSP6 | EDA | EDARADD | EFNB1 | EID2 | EXT2 | F11R | FAM120B | FAM210B | FGF2 | FGF4 | FGFR3 | FLNB | FNBP1 | FOXO1 | FRZB | FZD5 | GADD45G | GNA12 | GSK3B | HAND2 | HENMT1 | HERC4 | HIST1H4B | HLX | HSPA1L | HSPA2 | HUWE1 | IFT20 | INA | INHBA | INHBB | IQCG | JAM3 | JMJD6 | KAZALD1 | KLF4 | KLHL10 | LAMA5 | LFNG | LZIC | MAPK7 | MDGA1 | MEA1 | MEF2C | MGP | MITF | MLF1 | MMP19 | MOSMO | MOSPD1 | MYBL1 | NAV1 | NDRG4 | NGFR | NGRN | NOTCH2 | NOTCH2NLA | NRP1 | NRP2 | NTRK2 | ODF2 | OSR2 | PARD3 | PKDCC | PMP22 | PPP1R9B | PRDM16 | PTBP3 | PTMA | RAB29 | RACGAP1 | RAF1 | RARRES2 | RASAL1 | RASGRP4 | RBM45 | RFNG | RHOA | RIMBP3 | RNF114 | SCRIB | SDC2 | SEMA3B | SEMA4F | SEMA4G | SEMA7A | SERPINE2 | SETD2 | SFMBT1 | SFRP1 | SFRP2 | SH2B3 | SIRT1 | SLC2A14 | SLC7A5 | SLCO4C1 | SLIT3 | SMOC1 | SORT1 | SPAG4 | SPATA18 | SPP1 | SQSTM1 | SYNE1 | TBX18 | TCF21 | TGFBR2 | THOC5 | TLE3 | TMTC3 | TNFRSF12A | TNFSF12 | TRAPPC9 | TSNAX | TWIST2 | UBE2V1 | UHRF2 | USP42 | VEGFC | VEGFD | VIPAS39 | VPS25 | WNT1 | WNT11 | YIPF3 | YTHDF2 | ZBTB1 | ZHX3 | ZPR1 | ZSCAN21
1
20. 1-Methyl-3-isobutylxanthine cell differentiation Dexamethasone | INS [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS] results in increased cell differentiation 1: Mus musculus 3T3-L1 Cells
171 genes: AAMP | ABHD5 | ACVR1C | ADIRF | AGO2 | AGRN | AKT1 | ANGPT1 | ANGPTL4 | ANKRD49 | ARHGAP22 | ARHGEF2 | ARHGEF28 | BCL7B | BEX1 | BMP4 | BMP6 | BMP7 | BMPR1A | BNC1 | C9ORF24 | CAPRIN2 | CCDC136 | CDC42 | CDK6 | CEBPA | CEBPB | CENPF | CEP131 | CHRDL1 | CLIC4 | COL15A1 | CREB1 | CSF1 | CSRP2 | CTBP2 | CTNNB1 | DLK1 | DMKN | DOCK7 | DUSP6 | EDA | EDARADD | EFNB1 | EID2 | EXT2 | F11R | FAM120B | FAM210B | FGF2 | FGF4 | FGFR3 | FLNB | FNBP1 | FOXO1 | FRZB | FZD5 | GADD45G | GNA12 | GSK3B | HAND2 | HENMT1 | HERC4 | HIST1H4B | HLX | HSPA1L | HSPA2 | HUWE1 | IFT20 | INA | INHBA | INHBB | IQCG | JAM3 | JMJD6 | KAZALD1 | KLF4 | KLHL10 | LAMA5 | LFNG | LZIC | MAPK7 | MDGA1 | MEA1 | MEF2C | MGP | MITF | MLF1 | MMP19 | MOSMO | MOSPD1 | MYBL1 | NAV1 | NDRG4 | NGFR | NGRN | NOTCH2 | NOTCH2NLA | NRP1 | NRP2 | NTRK2 | ODF2 | OSR2 | PARD3 | PKDCC | PMP22 | PPP1R9B | PRDM16 | PTBP3 | PTMA | RAB29 | RACGAP1 | RAF1 | RARRES2 | RASAL1 | RASGRP4 | RBM45 | RFNG | RHOA | RIMBP3 | RNF114 | SCRIB | SDC2 | SEMA3B | SEMA4F | SEMA4G | SEMA7A | SERPINE2 | SETD2 | SFMBT1 | SFRP1 | SFRP2 | SH2B3 | SIRT1 | SLC2A14 | SLC7A5 | SLCO4C1 | SLIT3 | SMOC1 | SORT1 | SPAG4 | SPATA18 | SPP1 | SQSTM1 | SYNE1 | TBX18 | TCF21 | TGFBR2 | THOC5 | TLE3 | TMTC3 | TNFRSF12A | TNFSF12 | TRAPPC9 | TSNAX | TWIST2 | UBE2V1 | UHRF2 | USP42 | VEGFC | VEGFD | VIPAS39 | VPS25 | WNT1 | WNT11 | YIPF3 | YTHDF2 | ZBTB1 | ZHX3 | ZPR1 | ZSCAN21
1
21. 1-Methyl-3-isobutylxanthine cell differentiation Dexamethasone | INS [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased cell differentiation 1: Mus musculus 3T3-L1 Cells
171 genes: AAMP | ABHD5 | ACVR1C | ADIRF | AGO2 | AGRN | AKT1 | ANGPT1 | ANGPTL4 | ANKRD49 | ARHGAP22 | ARHGEF2 | ARHGEF28 | BCL7B | BEX1 | BMP4 | BMP6 | BMP7 | BMPR1A | BNC1 | C9ORF24 | CAPRIN2 | CCDC136 | CDC42 | CDK6 | CEBPA | CEBPB | CENPF | CEP131 | CHRDL1 | CLIC4 | COL15A1 | CREB1 | CSF1 | CSRP2 | CTBP2 | CTNNB1 | DLK1 | DMKN | DOCK7 | DUSP6 | EDA | EDARADD | EFNB1 | EID2 | EXT2 | F11R | FAM120B | FAM210B | FGF2 | FGF4 | FGFR3 | FLNB | FNBP1 | FOXO1 | FRZB | FZD5 | GADD45G | GNA12 | GSK3B | HAND2 | HENMT1 | HERC4 | HIST1H4B | HLX | HSPA1L | HSPA2 | HUWE1 | IFT20 | INA | INHBA | INHBB | IQCG | JAM3 | JMJD6 | KAZALD1 | KLF4 | KLHL10 | LAMA5 | LFNG | LZIC | MAPK7 | MDGA1 | MEA1 | MEF2C | MGP | MITF | MLF1 | MMP19 | MOSMO | MOSPD1 | MYBL1 | NAV1 | NDRG4 | NGFR | NGRN | NOTCH2 | NOTCH2NLA | NRP1 | NRP2 | NTRK2 | ODF2 | OSR2 | PARD3 | PKDCC | PMP22 | PPP1R9B | PRDM16 | PTBP3 | PTMA | RAB29 | RACGAP1 | RAF1 | RARRES2 | RASAL1 | RASGRP4 | RBM45 | RFNG | RHOA | RIMBP3 | RNF114 | SCRIB | SDC2 | SEMA3B | SEMA4F | SEMA4G | SEMA7A | SERPINE2 | SETD2 | SFMBT1 | SFRP1 | SFRP2 | SH2B3 | SIRT1 | SLC2A14 | SLC7A5 | SLCO4C1 | SLIT3 | SMOC1 | SORT1 | SPAG4 | SPATA18 | SPP1 | SQSTM1 | SYNE1 | TBX18 | TCF21 | TGFBR2 | THOC5 | TLE3 | TMTC3 | TNFRSF12A | TNFSF12 | TRAPPC9 | TSNAX | TWIST2 | UBE2V1 | UHRF2 | USP42 | VEGFC | VEGFD | VIPAS39 | VPS25 | WNT1 | WNT11 | YIPF3 | YTHDF2 | ZBTB1 | ZHX3 | ZPR1 | ZSCAN21
2
22. 1-Methyl-3-isobutylxanthine cell differentiation Dexamethasone | Glucose | INS Glucose inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS] results in increased cell differentiation] 1: Mus musculus 3T3-L1 Cells
171 genes: AAMP | ABHD5 | ACVR1C | ADIRF | AGO2 | AGRN | AKT1 | ANGPT1 | ANGPTL4 | ANKRD49 | ARHGAP22 | ARHGEF2 | ARHGEF28 | BCL7B | BEX1 | BMP4 | BMP6 | BMP7 | BMPR1A | BNC1 | C9ORF24 | CAPRIN2 | CCDC136 | CDC42 | CDK6 | CEBPA | CEBPB | CENPF | CEP131 | CHRDL1 | CLIC4 | COL15A1 | CREB1 | CSF1 | CSRP2 | CTBP2 | CTNNB1 | DLK1 | DMKN | DOCK7 | DUSP6 | EDA | EDARADD | EFNB1 | EID2 | EXT2 | F11R | FAM120B | FAM210B | FGF2 | FGF4 | FGFR3 | FLNB | FNBP1 | FOXO1 | FRZB | FZD5 | GADD45G | GNA12 | GSK3B | HAND2 | HENMT1 | HERC4 | HIST1H4B | HLX | HSPA1L | HSPA2 | HUWE1 | IFT20 | INA | INHBA | INHBB | IQCG | JAM3 | JMJD6 | KAZALD1 | KLF4 | KLHL10 | LAMA5 | LFNG | LZIC | MAPK7 | MDGA1 | MEA1 | MEF2C | MGP | MITF | MLF1 | MMP19 | MOSMO | MOSPD1 | MYBL1 | NAV1 | NDRG4 | NGFR | NGRN | NOTCH2 | NOTCH2NLA | NRP1 | NRP2 | NTRK2 | ODF2 | OSR2 | PARD3 | PKDCC | PMP22 | PPP1R9B | PRDM16 | PTBP3 | PTMA | RAB29 | RACGAP1 | RAF1 | RARRES2 | RASAL1 | RASGRP4 | RBM45 | RFNG | RHOA | RIMBP3 | RNF114 | SCRIB | SDC2 | SEMA3B | SEMA4F | SEMA4G | SEMA7A | SERPINE2 | SETD2 | SFMBT1 | SFRP1 | SFRP2 | SH2B3 | SIRT1 | SLC2A14 | SLC7A5 | SLCO4C1 | SLIT3 | SMOC1 | SORT1 | SPAG4 | SPATA18 | SPP1 | SQSTM1 | SYNE1 | TBX18 | TCF21 | TGFBR2 | THOC5 | TLE3 | TMTC3 | TNFRSF12A | TNFSF12 | TRAPPC9 | TSNAX | TWIST2 | UBE2V1 | UHRF2 | USP42 | VEGFC | VEGFD | VIPAS39 | VPS25 | WNT1 | WNT11 | YIPF3 | YTHDF2 | ZBTB1 | ZHX3 | ZPR1 | ZSCAN21
1
23. 1-Methyl-3-isobutylxanthine cell differentiation Dexamethasone | INS [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased cell differentiation 1: Rattus norvegicus Dental Pulp | Cells, Cultured
171 genes: AAMP | ABHD5 | ACVR1C | ADIRF | AGO2 | AGRN | AKT1 | ANGPT1 | ANGPTL4 | ANKRD49 | ARHGAP22 | ARHGEF2 | ARHGEF28 | BCL7B | BEX1 | BMP4 | BMP6 | BMP7 | BMPR1A | BNC1 | C9ORF24 | CAPRIN2 | CCDC136 | CDC42 | CDK6 | CEBPA | CEBPB | CENPF | CEP131 | CHRDL1 | CLIC4 | COL15A1 | CREB1 | CSF1 | CSRP2 | CTBP2 | CTNNB1 | DLK1 | DMKN | DOCK7 | DUSP6 | EDA | EDARADD | EFNB1 | EID2 | EXT2 | F11R | FAM120B | FAM210B | FGF2 | FGF4 | FGFR3 | FLNB | FNBP1 | FOXO1 | FRZB | FZD5 | GADD45G | GNA12 | GSK3B | HAND2 | HENMT1 | HERC4 | HIST1H4B | HLX | HSPA1L | HSPA2 | HUWE1 | IFT20 | INA | INHBA | INHBB | IQCG | JAM3 | JMJD6 | KAZALD1 | KLF4 | KLHL10 | LAMA5 | LFNG | LZIC | MAPK7 | MDGA1 | MEA1 | MEF2C | MGP | MITF | MLF1 | MMP19 | MOSMO | MOSPD1 | MYBL1 | NAV1 | NDRG4 | NGFR | NGRN | NOTCH2 | NOTCH2NLA | NRP1 | NRP2 | NTRK2 | ODF2 | OSR2 | PARD3 | PKDCC | PMP22 | PPP1R9B | PRDM16 | PTBP3 | PTMA | RAB29 | RACGAP1 | RAF1 | RARRES2 | RASAL1 | RASGRP4 | RBM45 | RFNG | RHOA | RIMBP3 | RNF114 | SCRIB | SDC2 | SEMA3B | SEMA4F | SEMA4G | SEMA7A | SERPINE2 | SETD2 | SFMBT1 | SFRP1 | SFRP2 | SH2B3 | SIRT1 | SLC2A14 | SLC7A5 | SLCO4C1 | SLIT3 | SMOC1 | SORT1 | SPAG4 | SPATA18 | SPP1 | SQSTM1 | SYNE1 | TBX18 | TCF21 | TGFBR2 | THOC5 | TLE3 | TMTC3 | TNFRSF12A | TNFSF12 | TRAPPC9 | TSNAX | TWIST2 | UBE2V1 | UHRF2 | USP42 | VEGFC | VEGFD | VIPAS39 | VPS25 | WNT1 | WNT11 | YIPF3 | YTHDF2 | ZBTB1 | ZHX3 | ZPR1 | ZSCAN21
1
24. 1-Methyl-3-isobutylxanthine gluconeogenesis GCG 1-Methyl-3-isobutylxanthine promotes the reaction [GCG protein results in increased gluconeogenesis] Hepatocytes
17 genes: ALDOA | ALDOC | CRTC2 | ENO1 | ENO2 | ENO3 | GAPDH | GOT1 | GPD1 | MDH2 | PCK1 | PCX | PER2 | PPARGC1A | RBP4 | SLC25A1 | SLC25A10
1
25. 1-Methyl-3-isobutylxanthine gluconeogenesis Isoproterenol 1-Methyl-3-isobutylxanthine promotes the reaction [Isoproterenol results in increased gluconeogenesis] 1: Rattus norvegicus Hepatocytes
17 genes: ALDOA | ALDOC | CRTC2 | ENO1 | ENO2 | ENO3 | GAPDH | GOT1 | GPD1 | MDH2 | PCK1 | PCX | PER2 | PPARGC1A | RBP4 | SLC25A1 | SLC25A10
1
26. 1-Methyl-3-isobutylxanthine cell differentiation 8-Bromo Cyclic Adenosine Monophosphate | Dexamethasone [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased cell differentiation 1: Homo sapiens Fetus | Lung | Epithelial Cells
171 genes: AAMP | ABHD5 | ACVR1C | ADIRF | AGO2 | AGRN | AKT1 | ANGPT1 | ANGPTL4 | ANKRD49 | ARHGAP22 | ARHGEF2 | ARHGEF28 | BCL7B | BEX1 | BMP4 | BMP6 | BMP7 | BMPR1A | BNC1 | C9ORF24 | CAPRIN2 | CCDC136 | CDC42 | CDK6 | CEBPA | CEBPB | CENPF | CEP131 | CHRDL1 | CLIC4 | COL15A1 | CREB1 | CSF1 | CSRP2 | CTBP2 | CTNNB1 | DLK1 | DMKN | DOCK7 | DUSP6 | EDA | EDARADD | EFNB1 | EID2 | EXT2 | F11R | FAM120B | FAM210B | FGF2 | FGF4 | FGFR3 | FLNB | FNBP1 | FOXO1 | FRZB | FZD5 | GADD45G | GNA12 | GSK3B | HAND2 | HENMT1 | HERC4 | HIST1H4B | HLX | HSPA1L | HSPA2 | HUWE1 | IFT20 | INA | INHBA | INHBB | IQCG | JAM3 | JMJD6 | KAZALD1 | KLF4 | KLHL10 | LAMA5 | LFNG | LZIC | MAPK7 | MDGA1 | MEA1 | MEF2C | MGP | MITF | MLF1 | MMP19 | MOSMO | MOSPD1 | MYBL1 | NAV1 | NDRG4 | NGFR | NGRN | NOTCH2 | NOTCH2NLA | NRP1 | NRP2 | NTRK2 | ODF2 | OSR2 | PARD3 | PKDCC | PMP22 | PPP1R9B | PRDM16 | PTBP3 | PTMA | RAB29 | RACGAP1 | RAF1 | RARRES2 | RASAL1 | RASGRP4 | RBM45 | RFNG | RHOA | RIMBP3 | RNF114 | SCRIB | SDC2 | SEMA3B | SEMA4F | SEMA4G | SEMA7A | SERPINE2 | SETD2 | SFMBT1 | SFRP1 | SFRP2 | SH2B3 | SIRT1 | SLC2A14 | SLC7A5 | SLCO4C1 | SLIT3 | SMOC1 | SORT1 | SPAG4 | SPATA18 | SPP1 | SQSTM1 | SYNE1 | TBX18 | TCF21 | TGFBR2 | THOC5 | TLE3 | TMTC3 | TNFRSF12A | TNFSF12 | TRAPPC9 | TSNAX | TWIST2 | UBE2V1 | UHRF2 | USP42 | VEGFC | VEGFD | VIPAS39 | VPS25 | WNT1 | WNT11 | YIPF3 | YTHDF2 | ZBTB1 | ZHX3 | ZPR1 | ZSCAN21
1
27. 1-Methyl-3-isobutylxanthine adipose tissue development Dexamethasone | INS [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased adipose tissue development Adipocytes
10 genes: ACAT1 | AP1S2 | CDK4 | FTO | HMGA2 | ID2 | LEP | NAMPT | OXCT1 | PPARGC1A
1
28. 1-Methyl-3-isobutylxanthine adipose tissue development Dexamethasone | INS | rhodostomin rhodostomin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS] results in increased adipose tissue development] Adipocytes
10 genes: ACAT1 | AP1S2 | CDK4 | FTO | HMGA2 | ID2 | LEP | NAMPT | OXCT1 | PPARGC1A
1
29. 1-Methyl-3-isobutylxanthine adipose tissue development Dexamethasone | INS1 [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased adipose tissue development 1: Mus musculus 3T3-L1 Cells
10 genes: ACAT1 | AP1S2 | CDK4 | FTO | HMGA2 | ID2 | LEP | NAMPT | OXCT1 | PPARGC1A
1
30. 1-Methyl-3-isobutylxanthine adipose tissue development Dexamethasone | INS1 | Ritonavir Ritonavir promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased adipose tissue development] 1: Mus musculus 3T3-L1 Cells
10 genes: ACAT1 | AP1S2 | CDK4 | FTO | HMGA2 | ID2 | LEP | NAMPT | OXCT1 | PPARGC1A
1
31. 1-Methyl-3-isobutylxanthine regulation of cell size 1-Methyl-3-isobutylxanthine results in decreased regulation of cell size 1: Mus musculus Macrophages | Cell Line
6 genes: ARHGAP5 | CREB1 | LAMTOR5 | PTEN | RPTOR | STAT3
1
32. 1-Methyl-3-isobutylxanthine adipose tissue development 1-Methyl-3-isobutylxanthine results in increased adipose tissue development 1: Rattus norvegicus Bone Marrow Cells | Cells, Cultured
10 genes: ACAT1 | AP1S2 | CDK4 | FTO | HMGA2 | ID2 | LEP | NAMPT | OXCT1 | PPARGC1A
1
33. 1-Methyl-3-isobutylxanthine adipose tissue development Metformin Metformin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased adipose tissue development] 1: Rattus norvegicus Bone Marrow Cells | Cells, Cultured
10 genes: ACAT1 | AP1S2 | CDK4 | FTO | HMGA2 | ID2 | LEP | NAMPT | OXCT1 | PPARGC1A
1
34. 1-Methyl-3-isobutylxanthine adipose tissue development Dexamethasone | INS [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased adipose tissue development 1: Homo sapiens Bone Marrow Cells | Mesenchymal Stem Cells | Cells, Cultured
10 genes: ACAT1 | AP1S2 | CDK4 | FTO | HMGA2 | ID2 | LEP | NAMPT | OXCT1 | PPARGC1A
1
35. 1-Methyl-3-isobutylxanthine adipose tissue development Dexamethasone | INS | Rosiglitazone Rosiglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased adipose tissue development] 1: Homo sapiens Bone Marrow Cells | Mesenchymal Stem Cells | Cells, Cultured
10 genes: ACAT1 | AP1S2 | CDK4 | FTO | HMGA2 | ID2 | LEP | NAMPT | OXCT1 | PPARGC1A
1
36. 1-Methyl-3-isobutylxanthine adipose tissue development Dexamethasone | INS | Rosiglitazone [Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased adipose tissue development 1: Homo sapiens Bone Marrow Cells | Mesenchymal Stem Cells | Cells, Cultured
10 genes: ACAT1 | AP1S2 | CDK4 | FTO | HMGA2 | ID2 | LEP | NAMPT | OXCT1 | PPARGC1A
1
37. 1-Methyl-3-isobutylxanthine adipose tissue development Dexamethasone | INS | Rosiglitazone | TGFB1 TGFB1 protein inhibits the reaction [[Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased adipose tissue development] 1: Homo sapiens Bone Marrow Cells | Mesenchymal Stem Cells | Cells, Cultured
10 genes: ACAT1 | AP1S2 | CDK4 | FTO | HMGA2 | ID2 | LEP | NAMPT | OXCT1 | PPARGC1A
1
38. 1-Methyl-3-isobutylxanthine glycogen catabolic process 1-Methyl-3-isobutylxanthine results in increased glycogen catabolic process 1: Rattus norvegicus Hepatocytes 1 gene: ADRB1 1
39. 1-Methyl-3-isobutylxanthine adipose tissue development Dexamethasone | INS1 [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1] results in increased adipose tissue development 1: Mus musculus 3T3-L1 Cells
10 genes: ACAT1 | AP1S2 | CDK4 | FTO | HMGA2 | ID2 | LEP | NAMPT | OXCT1 | PPARGC1A
1
40. 1-Methyl-3-isobutylxanthine adipose tissue development Dexamethasone | INS1 | Wortmannin Wortmannin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1] results in increased adipose tissue development] 1: Mus musculus 3T3-L1 Cells
10 genes: ACAT1 | AP1S2 | CDK4 | FTO | HMGA2 | ID2 | LEP | NAMPT | OXCT1 | PPARGC1A
1
41. 1-Methyl-3-isobutylxanthine adipose tissue development Dexamethasone | INS1 | Simvastatin Simvastatin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1] results in increased adipose tissue development] 1: Mus musculus 3T3-L1 Cells
10 genes: ACAT1 | AP1S2 | CDK4 | FTO | HMGA2 | ID2 | LEP | NAMPT | OXCT1 | PPARGC1A
1
42. 1-Methyl-3-isobutylxanthine glycogen catabolic process GCG 1-Methyl-3-isobutylxanthine promotes the reaction [GCG protein results in increased glycogen catabolic process] Hepatocytes | Cells, Cultured 1 gene: ADRB1 1
43. 1-Methyl-3-isobutylxanthine adipose tissue development 1-Methyl-3-isobutylxanthine results in increased adipose tissue development 1: Mus musculus Bone Marrow | Stromal Cells | Cells, Cultured
10 genes: ACAT1 | AP1S2 | CDK4 | FTO | HMGA2 | ID2 | LEP | NAMPT | OXCT1 | PPARGC1A
1
44. 1-Methyl-3-isobutylxanthine adipose tissue development Calcitriol Calcitriol inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased adipose tissue development] 1: Mus musculus Bone Marrow | Stromal Cells | Cells, Cultured
10 genes: ACAT1 | AP1S2 | CDK4 | FTO | HMGA2 | ID2 | LEP | NAMPT | OXCT1 | PPARGC1A
1
45. 1-Methyl-3-isobutylxanthine adipose tissue development 1-Methyl-3-isobutylxanthine results in increased adipose tissue development 1: Mus musculus Bone Marrow | Stromal Cells | Cell Line
10 genes: ACAT1 | AP1S2 | CDK4 | FTO | HMGA2 | ID2 | LEP | NAMPT | OXCT1 | PPARGC1A
1
46. 1-Methyl-3-isobutylxanthine adipose tissue development Calcitriol Calcitriol inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased adipose tissue development] 1: Mus musculus Bone Marrow | Stromal Cells | Cell Line
10 genes: ACAT1 | AP1S2 | CDK4 | FTO | HMGA2 | ID2 | LEP | NAMPT | OXCT1 | PPARGC1A
1
47. 1-Methyl-3-isobutylxanthine regulation of membrane potential 1-Methyl-3-isobutylxanthine results in decreased regulation of membrane potential 1: Mus musculus Oviducts | Muscle, Smooth
7 genes: CACNA1G | CACNA1H | CACNA1I | DLG1 | KCNH2 | KCNMA1 | PIEZO2
1
48. 1-Methyl-3-isobutylxanthine leukocyte chemotaxis Isoproterenol | N-Formylmethionine Leucyl-Phenylalanine 1-Methyl-3-isobutylxanthine affects the reaction [Isoproterenol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased leukocyte chemotaxis]] 1: Homo sapiens Neutrophils
4 genes: CKLF | CX3CL1 | CXCL2 | PF4
1
49. 1-Methyl-3-isobutylxanthine leukocyte chemotaxis Alprostadil | N-Formylmethionine Leucyl-Phenylalanine 1-Methyl-3-isobutylxanthine affects the reaction [Alprostadil inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased leukocyte chemotaxis]] 1: Homo sapiens Neutrophils
4 genes: CKLF | CX3CL1 | CXCL2 | PF4
1
50. 1-Methyl-3-isobutylxanthine leukocyte chemotaxis Colforsin | N-Formylmethionine Leucyl-Phenylalanine 1-Methyl-3-isobutylxanthine affects the reaction [Colforsin inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased leukocyte chemotaxis]] 1: Homo sapiens Neutrophils
4 genes: CKLF | CX3CL1 | CXCL2 | PF4
1
1–50 of 1,133 results.